News | November 28, 2017

Omnicell Introduces Revolutionary New Solution To Automate Critical Workflows In Central Pharmacy

XR2 Automated Central Pharmacy System Enhances Control, Efficiency, and Safety for Medication Inventory Management

Mountain View, CA /PRNewswire/ - Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations, today announced revolutionary new technology that more fully automates medication inventory management, allowing pharmacies to make a meaningful shift from operational demands to clinical contributions that impact patient outcomes.

The Omnicell® XR2 Automated Central Pharmacy System, designed with input from leading health system pharmacies, streamlines critical workflows to maximize inventory control, improve operational efficiency, and increase medication safety. The system utilizes robotic technology to eliminate numerous manual tasks, freeing up time for more value-added work.

"With XR2, we can reallocate resources to support population health initiatives," said Glenn Huth, RPh, director of pharmacy operations at Summa Health. "Rather than focusing on medication inventory work in the pharmacy, our staff can get out on the floor to interact with nurses, physicians, and patients from the point of admission to discharge, which will help lead to improved patient outcomes."

Designed to meet the unique and evolving needs of pharmacy operations, XR2 supports health systems with either centralized or decentralized models, with or without existing pharmacy automation.

The XR2 automated system is a key technological step toward the fully automated pharmacy. Hospital systems deploying the XR2 system can benefit from the following operational efficiencies:

  • Financial returns through improved automation and better inventory management
  • Pharmacist verification exemption that can reduce staff burden
  • Reducing medication waste cost through earliest to expire dispensing algorithms
  • Eliminating the time and expense of repackaging medications

A number of hospital systems with both centralized and decentralized models already have signed commercial agreements to implement the XR2 system. The XR2 system is part of Omnicell's autonomous approach to medication management, leveraging hardware and workflow solutions, real-time predictive intelligence, and performance-driven partnerships to drive ongoing satisfaction and transform patient-centered care. To learn more, visit Omnicell.com/xr2.

Omnicell will be showcasing its broad portfolio of solutions at the American Society of Health-System Pharmacists (ASHP) 52nd Annual Midyear Clinical Meeting & Exhibition in Orlando, December 4 through 7. Visit Booth #1101 to learn more.

About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

The Omnicell SureMed® solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. These medication adherence solutions are used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are served via Omnicell's sales channels and our solutions enable them to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

Recent acquisitions, including Ateb, have added distinct capabilities, particularly in central pharmacy, IV robotics and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-G

Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

SOURCE: Omnicell, Inc.

Copyright 2017 PR Newswire. All Rights Reserved